Cardio‐Selective Beta‐Blocker: Pharmacological Evidence and Their Influence on Exercise Capacity
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
SUMMARY For the past 40 years, beta‐blockers have been widely used in cardiovascular medicine, reducing morbidity as well as mortality. Beta‐blockers are currently used in a number of cardiovascular conditions such as systolic heart failure, postmyocardial infarction, and in prevention and treatment of arrhythmias. They are not recommended as the first line antihypertensive therapy, particularly in the elderly, unless there are specific indications. Despite the benefits of beta‐blockers, tolerability concerns in patients with co‐morbidities have limited their use. Some of these problems were overcome with the discovery of cardioselective beta‐blockers. The third generation beta‐blockers have additional properties of vasodilatation and advantages in terms of minimizing the adverse effects of beta‐blockers. Some of the advantages include improvement of insulin resistance, decrease in cholesterol as well as alleviation of erectile dysfunction. Acute treatment with beta‐blockers modifies local muscular metabolic properties and impairs endurance exercise capacity whereas the influence of chronic is debated controversially.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
beta Blockade after myocardial infarction: systematic review and meta regression analysis
Freemantle, N., Cleland, J., Young, P., Mason, J., & Harrison, J. (1999) · BMJ · doi:10.1136/bmj.318.7200.1730 · Cited by 1,509
Adverse consequences of high sympathetic nervous activity in the failing human heart
Kaye, D. M., Lefkovits, J., Jennings, G. L., Bergin, P., Broughton, A., & Esler, M. D. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00332-0 · Cited by 665
(2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.002 · Cited by 557
Miura, S., Kawanaka, K., Kai, Y., Tamura, M., Goto, M., Shiuchi, T., Minokoshi, Y., & Ezaki, O. (2007) · Endocrinology · doi:10.1210/en.2006-1646 · Cited by 183
Acute emotional stress and cardiac arrhythmias
Ziegelstein, R. C. (2007) · JAMA · doi:10.1001/jama.298.3.324 · Cited by 146
Ades, P. A., Gunther, P. G. S., Meyer, W. L., Gibson, T. C., Maddalena, J., & Orfeo, T. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90486-k · Cited by 25
Cited by
Insulin Resistance and Heart Failure
Aroor, A. R., Mandavia, C. H., & Sowers, J. R. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.005 · Cited by 252
Sympathetic β1-adrenergic signaling contributes to regulation of human bone metabolism
Khosla, S., Drake, M. T., Volkman, T. L., Thicke, B. S., Achenbach, S. J., Atkinson, E. J., Joyner, M. J., Rosen, C. J., Monroe, D. G., & Farr, J. N. (2018) · Journal of Clinical Investigation · doi:10.1172/jci122151 · Cited by 132
“Moreover, as no clinically available β2-AR–selective antagonists exist, we took advantage of the β1-AR selectivity gradient of these drugs (propranolol [nonselective] << atenolol [relatively β1-AR selective/some β2-AR antagonism] < nebivolol [highly β1-AR selective]) (19, 20) to define the β-AR selectivity for SNS eff…”
BackgroundThe crosstalk between bone remodeling and energy metabolism: A translational perspective
Karsenty, G., & Khosla, S. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.04.010 · Cited by 113
Low-dose propranolol and exercise capacity in postural tachycardia syndrome: A randomized study
Arnold, A. C., Okamoto, L. E., Diedrich, A., Paranjape, S. Y., Raj, S. R., Biaggioni, I., & Gamboa, A. (2013) · Neurology · doi:10.1212/wnl.0b013e318293e310 · Cited by 65
Prokopidis, K., Giannos, P., Reginster, J. Y., Bruyere, O., Petrovic, M., Cherubini, A., Triantafyllidis, K. K., Kechagias, K. S., Dionyssiotis, Y., Cesari, M., et al. (2023) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13190 · Cited by 51
Metadata
- Authors
- Ladage, D., Schwinger, R. H. G., & Brixius, K.
- Venue
- Cardiovascular Therapeutics
- Publisher
- Wiley
- Published
- 2012-01-26
- Volume
- 31
- Issue
- 2
- Pages
- 76-83
- ISSN
- 1755-5914 (ISSN-L)
- 1755-5922
- OpenAlex
- W1579735552
- Cited by
- 107
- References
- 7
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardio‐Selective Beta‐Blocker: Pharmacological Evidence and Their Influence on Exercise Capacity. https://app.cochat.ai/papers/10.1111/j.1755-5922.2011.00306.x
- The paper
- Ladage, D., Schwinger, R. H. G., & Brixius, K. (2013). Cardio‐Selective Beta‐Blocker: Pharmacological Evidence and Their Influence on Exercise Capacity. Cardiovascular Therapeutics. https://doi.org/10.1111/j.1755-5922.2011.00306.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.